Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
175.8 USD | +1.94% | +6.42% | -2.05% |
02/05 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
01/05 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.00% | 9.64B | |
-5.07% | 181B | |
+2.45% | 112B | |
-2.64% | 67.92B | |
+4.73% | 50.1B | |
+8.03% | 44.27B | |
+9.39% | 40.41B | |
+24.67% | 31.95B | |
-0.23% | 25.82B | |
+17.27% | 25.29B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Transcript : Repligen Corporation, Q1 2024 Earnings Call, May 01, 2024